Dr. Pier Jr Morin, PhD, MBA
Associate Professor – Biochemistry, Department of Chemistry and Biochemistry, Université de Moncton; Adjunct Professor – Biochemistry, Department of Biochemistry, Université de Sherbrooke
Université de Moncton (primary)
Université de Sherbrooke (cross-appointment)
Cellular signaling, kinases, brain tumours, glioblastomas
Targeting the kinome in glioblastomas
Glioblastoma multiforme (GBM) is an aggressive brain tumor for which current therapeutic approaches are limited. Dr. Morin and his research team focus on the identification of hyperactivated signaling pathways involved in the biogenesis and development of GBMs and which could serve as sites for targeted therapeutic intervention. Differentially regulated protein kinases, key mediators of signal transduction and druggable targets, are characterized in primary GBM tumours and cell lines.